Hexavalent chromium (Cr(VI)) is detected in U.S. public drinking water at an average concentration of 0.002 ppm (U.S. EPA, 2017) . Studies in rodents indicate that exposure to 50 ppm Cr(VI) (It is unclear whether this is 50 ppm Cr(VI) ion or 50 ppm potassium dichromate.) increases markers of oxidative stress in placental tissue (Banu et al., 2017) . It has been demonstrated that exposure to such high levels of Cr(VI) overwhelm protective reductive processes that otherwise limit Cr(VI) bioavailability (Kirman et al., 2017) . We therefore read with great interest a new report in Toxicological Sciences that chromium levels in human placentas obtained from a Michigan hospital were associated with increased markers of oxidative stress and apoptosis (Banu et al., 2018) . According to data collected by the U.S. EPA, the average Cr(VI) concentration in 1371 water samples in Michigan is 0.00014 ppm, with a maximum reported detection of 0.0015 ppm (U.S. EPA, 2017). Thus, the highest detected levels of Cr(VI) in Michigan are 30 000 lower than those that caused placental effects in rodents. Human pharmacokinetic data indicate that Cr(VI) levels present in U.S. drinking water are well within the capacity of gastric fluid to reduce Cr(VI) to Cr(III) (Kirman et al., 2017) . Therefore, we believe that the attribution of the oxidative stress in human placentas to environmental exposure to Cr(VI) is not biologically plausible, and that methodological issues in Banu et al. (2018) further weaken any such association.
The 50 placentas collected by Banu et al. (2018) were deidentified and thus relatively little is known about the mothers or birth outcomes. As such, sources of chromium exposure such as occupation, prenatal vitamin use, and treatment received while in the hospital are unknown. Furthermore, it is common to use Cr-free instruments to collect tissues for inductively coupled plasma mass spectrometry; however, Banu et al. (2018) do not indicate whether such instruments were used. It is therefore conceivable that some placental samples were contaminated with small pieces of stainless steel from medical/cutting instruments. Banu et al. also provide no details on the time from delivery to sample stabilization, which likely influences the variability in oxidative stress across the 50 samples.
Critically, the potential for confirmation bias is high in this study. First, Banu et al. state that many metals "accumulate" in the placenta, yet accumulation can only be determined by sampling over time. Second, Banu et al. omitted 30 of the 50 placental samples from biochemical analyses. For each sex, the 5 placentas with the lowest Cr and the 5 placentas with the highest Cr concentration comprised the experimental groups. Visual inspection of Figure 1 in their paper seems to indicate 3 clusters, with the majority of samples forming a low Cr cluster. The Banu et al. findings might be more informative if all samples had been examined in order to test for correlations between placenta Cr concentration and oxidative stress. Third, and most importantly, Banu et al. only measured Cr and therefore attribute their findings of oxidative stress to Cr. Only in the last sentence of the paper do they acknowledge that "metals such as Cd, Ni, As, and Mn and other endocrine disruptors in the placenta may have also played a role in the development of such adverse effects." The human placenta weighs approximately 600 g (ICRP, 2002), so there was likely sufficient tissue to measure these other metals.
The presentation of results for mRNA and protein expression is confusing. The y-axis in Figure 3 , "mRNA(fold change)", is unclear as there is no reference group from which to calculate fold change. The Western analyses presented in Figure 4 are far from transparent, as small snippets of bands are shown (some vertical, some horizontal) rather than intact Western blots with samples loaded into adjacent lanes. The Methods indicate that samples were run on 7.5%, 10%, or 12% SDS-PAGE, but it is not specified which samples were run on each gel or how exactly the plots were normalized and quantified. The Western data should be presented in a clear and convincing manner in order to support the potentially important findings of oxidative stress in human placentas; however, this is not the case.
In the Discussion, Banu et al. compare placental Cr concentrations (0.02-1.25 ppm) with drinking water standards (0.05-0.1 ppm) and comment that the placental levels are similar to "levels of Cr in the worst contaminated places in the country". Notwithstanding the aforementioned concerns about placental Cr measurements and the low Cr(VI) levels measured in Michigan, this comparison demonstrates a gross misunderstanding of toxicity criteria, which is unfortunate for a publication in Toxicological Sciences. Other misleading statements include "environmental exposure to Cr(VI) is increasing and is a growing concern", for which no data are cited to demonstrate that exposure is increasing. Banu et al. state that "significant contamination with CrVI has been found in approximately 30% of the drinking water sources in California"; however, it is unclear what is meant by "significant" in this context. The aforementioned environmental monitoring data indicate that among 10 008 samples taken in California, the average concentration was 0.002 ppm with a 95th percentile value of 0.0093 ppm and maximum detected value of 0.047 ppm (U.S. EPA, 2017).
The findings in Banu et al. (2018) are undermined by methodological issues. Environmental monitoring and pharmacokinetic data also limit biological plausibility.
SUPPLEMENTARY DATA
Supplementary data are available at Toxicological Sciences online.
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